Skip to Content

BlackRock Health Sciences Opps Inv C SHSCX

Medalist Rating as of | See BlackRock Investment Hub
  • NAV / 1-Day Return 57.77  /  +1.28 %
  • Total Assets 8.5 Bil
  • Adj. Expense Ratio
    1.850%
  • Expense Ratio 1.850%
  • Distribution Fee Level Below Average
  • Share Class Type Level Load
  • Category Health
  • Investment Style Large Blend
  • Min. Initial Investment 1,000
  • Status Open
  • TTM Yield
  • Turnover 29%

USD | NAV as of Mar 02, 2024 | 1-Day Return as of Mar 02, 2024, 1:59 AM GMT+0

Morningstar’s Analysis SHSCX

Will SHSCX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Strength in BlackRock Health Sciences Opps Inv C's People Pillar is partially offset by an Average Process Pillar rating, leading to a Morningstar Medalist Rating of Neutral.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the most expensive quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings SHSCX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 48.2
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

UnitedHealth Group Inc

8.80 731.3 Mil
Healthcare

Eli Lilly and Co

8.75 726.4 Mil
Healthcare

AbbVie Inc

5.07 421.5 Mil
Healthcare

Boston Scientific Corp

4.77 396.4 Mil
Healthcare

Merck & Co Inc

4.66 387.0 Mil
Healthcare

Amgen Inc

3.98 330.3 Mil
Healthcare

Abbott Laboratories

3.56 295.7 Mil
Healthcare

Danaher Corp

3.14 260.7 Mil
Healthcare

Stryker Corp

2.73 227.0 Mil
Healthcare

Intuitive Surgical Inc

2.71 225.1 Mil
Healthcare